<- Go Home
Soliton, Inc.
Soliton, Inc., a medical device company, develops and commercializes products using a proprietary rapid acoustic pulse technology platform. The company offers products for the removal of tattoos. It also develops a product for cellulite reduction, fibrotic scar treatment, and other indications. The company was incorporated in 2012 and is based in Houston, Texas. Soliton, Inc. operates as a subsidiary of AbbVie Inc.
Market Cap
$487.6M
Volume
348.3K
Cash and Equivalents
$21.7M
EBITDA
-$23.2M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$26.0K
Profit Margin
7.03%
52 Week High
$22.60
52 Week Low
$7.40
Dividend
N/A
Price / Book Value
22.82
Price / Earnings
-26.88
Price / Tangible Book Value
23.17
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
-$23.8M
Return on Equity
63.97%
Return on Assets
-47.56
Cash and Short Term Investments
$21.7M
Debt
N/A
Equity
$21.4M
Revenue
$370.0K
Unlevered FCF
-$10.1M
Sector
Health Care Equipment and Supplies
Category
N/A